PART 2 DOWN THE RABBIT HOLE
Nemagen Discoveries Inc. NIH, NATO CAGE CODE AND COVID RESEARCH IN 2019
This substack WILL SHOW
That covid was likely circulating in 2019; That relevant parties in WHO and NIH knew urgent therapeutics were needed for processes involving lung inflammation; that they invested in Nemagen in 2019 to develop these therapeutics
Let’s go down the Rabbit hole
So going through the Covid ITW Security Group Inc. on the Open Gov Us site for ‘doing business’ with the government quickly led me to a nearby business that I found using postal code look ups. This Postal Code has a real hub of government contracts. All of this is public information and searchable and should be since government contracts should have some transparency.
Nemagen Discoveries Inc ·
2 Wheatfield Rd, Cranbury, NJ 08512-3220
Overview
NEMAGEN DISCOVERIES INC is ALSO an entity in Cranbury, New Jersey registered with the System for Award Management (SAM) of U.S. General Services Administration (GSA).
The entity was registered on October 1, 2019 with Unique Entity ID (UEI) #HKYGQCNGSN55, activated on May 4, 2022, expiring on May 2, 2023, and the business was started on September 9, 2019. (I believe that was the date they got the GOV contract- or may be the application).
The registered business location is at 2 Wheatfield Rd, Cranbury, NJ 08512-3220.
The current status is Active.
The entity structure is 2L - Corporate Entity (Not Tax Exempt). The business types are 2X - For Profit Organization.
The officers of the entity include Mark Siracusa (PRESIDENT).
Entity Information
SAM ID HKYGQCNGSN55
Unique Entity ID by SAM
NCAGE Code 8F3F6
Commercial and Government Entity (CAGE) Code by NATO Codification System
Legal Name NEMAGEN DISCOVERIES INC
Company Division NEMAGEN DISCOVERIES, INC
Physical Address 2 Wheatfield Rd Cranbury NJ 08512-3220
Mailing Address 155 Village Blvd. # 130 Princeton NJ 08540-3220
Incorporation State DE Business Type 2X - For Profit Organization
Registration Date October 1, 2019
Activation Date May 4, 2022
Business Start Date September 9, 2019
Registration Purpose Z1 - Federal Assistance Awards
WHAT is the CAGE CODE for
They have a CAGE Code 8F3F6. that was found in the Nato search tool.
The Commercial and Government Entity Code also known as CAGE Code, is a code assigned to businesses providing a product or service to the United States (U.S.) Government. In the NATO Codification System community, it's referred to as NATO Commercial and Government Entity Code also known as NCAGE Code.
This CAGE CODE is NOT DETERMINABLE ON A SEARCH OF CAGE GODES.
However it was located in the NCAGE Code Request Tool image below
According to the Nato WEBSITE
https://eportal.nspa.nato.int/Codification/Support/en/Products/NCAGE/
What is NCAGE code?
NATO Commercial and Government Entity code is primarily entity identifier within NATO Codification System (NCS), which holds the name, address and contact details of the organization. NCAGE codes are recognized throughout the international community and broadly used in many countries in a variety of logistics and administration processes, like a System for Award Management (SAM) registration in USA.
What is the difference between an NCAGE and a CAGE code?
They are the same; however, the US drops the N to call it a CAGE code as they use this throughout their Government system and not just within Defence forces.
Is there any meaning behind NCAGE code structure?
Every NATO Codification System (NCS) member nation has own unique NCAGE code structure assigned. NSPA assigns NCAGE codes for entities from non-NCS nations with structure S***# and I***# for supranational organizations.
WHAT DOES NEMJEN DO?
Develop novel therapeutics for the treatment of mastocytosis;
“NemaGen's cutting-edge neuroimmunology studies have revealed that the neuropeptide NMB is a potent inhibitor of lung inflammation. Lung diseases including COVID-19 represent the leading cause of death in the world and novel therapeutics are desperately needed to prevent lung inflammation. This program is advancing NMB delivery strategies to treat both acute and chronic inflammatory responses in the lung.” NEMAGEN TECHNOLOGY
So wait they get a grant/ or funding or investment prior to covid NIH/ that focuses on studying the mechanism of Lung Inflammation and acute and chronic inflammatory responses in the lung that can occur with covid.
NemaGen Investors;
According to Pitch book the National Institutes of Health is a Government Investor
and Foundation Venture Capital Group is a Venture Capital Minority Investor.
They can be found at this WEBSITE https://www.foundationventure.com/
NIH allegedly “works to prevent disease and improve health”.
NIH AN ARM OF THE WHO
Is it also an arm/satellite of the WHO though most people have no idea;
NIH was created specifically for the purpose of implementing WHO’s directives on global public health, pursuant to WHO HEALTH REGULATIONS.
WHO HEALTH REGULATIONS
the 2005 3RD EDITIONS STATES:
Article 4 Responsible authorities
1. Each State Party shall designate or establish a NATIOINAL IHR FOCAL POINT and the authorities responsible within its respective jurisdiction for the implementation of health measures under these Regulations.
2. National IHR Focal Points shall be accessible at all times for communications with the WHO IHR Contact Points provided for in paragraph 3 of this Article.
The functions of National IHR Focal Points shall include:
(a) sending to WHO IHR Contact Points, on behalf of the State Party concerned, urgent communications concerning the implementation of these Regulations, in particular under Articles 6 to 12; and
(b) disseminating information to, and consolidating input from, relevant sectors of the administration of the State Party concerned, including those responsible for surveillance and reporting, points of entry, public health services, clinics and hospitals and other government departments.
3. WHO shall designate IHR Contact Points, which shall be accessible at all times for communications with National IHR Focal Points. WHO IHR Contact Points shall send urgent communications concerning the implementation of these Regulations, in particular under Articles 6 to 12, to the National IHR Focal Point of the States Parties concerned.
WHO IHR Contact Points may be designated by WHO at the headquarters or at the regional level of the Organization.
4. States Parties shall provide WHO with contact details of their National IHR Focal Point and WHO shall provide States Parties with contact details of WHO IHR Contact Points. These contact details shall be continuously updated and annually confirmed. WHO shall make available to all States Parties the contact details of National IHR Focal Points it receives pursuant to this Article
Back to the rabbit hole what do we know
Nemajen gets a contract from the government and Registers with SAM on September 9, 2019;
And is active by October 1, 2019;
It’s major Investor is the NIH;
Which we understand in a branch of the WHO;
It’s given a NATO code;
It’s only research area is developing novel therapeutics lung inflammation that occurs in COVID 19 and they reference that precise research on their site;
The cytokine storm activation is one of the reasons Covid was lethal;
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19;
What we do know looks pretty damning. Was a lab release circulating in 2019; Did someone in WHO and NIH know urgent therapeutics were needed for processes involving lung inflammation? It sure looks like it.
FYI I’m not done. If you share this story. Please share my substack. If its useful consider a paid subscription. I appreciate all my readers. Thank you.
Do you think the truth will ever come out? Or will we still be talking about all this in 20 years?
I'm going to try to redo this post to set out the dates and configures and do a video with it. The timeline in this post disagrees with the congressional hearing going on right now.